Management Discussion and Analysis For the Annual Operating Results 2018 Ended December 31, 2018 Note: This Management Discussion and Analysis (MD&A) was made to disclose information and the vision

hence the Company needs to disclose information to the Stock Exchange of Thailand and notify its shareholders by letter within 21 days from the date disclose information to the Stock Exchange of Thailand

arrangement for transfer and any transfer restriction of the debt securities. 6. Disclose the currency the debt securities are denominated as well as the currency in which any amount payable on the debt

ordinary shares of Modern Pharma Company Limited is a subsidiary of the Company, the Company, therefore, has a duty to disclose the transaction information of the Company to the Stock Exchange of Thailand

. Governing law Thai law 7. Approved the expansion of the flexible packaging business in the amount of Baht 75 million, comprising the construction of a factory warehouse at Baht 35 million and the purchase of

unless deposits are demanded without interest. 8. Governing law Thai law 7. Approved the expansion of the flexible packaging business in the amount of Baht 75 million, comprising the construction of a

Industry Public Company Limited (“KSL”). Therefore, to effectively seek additional sources of fund as a channel of fund raising to adequately support the expansion, enhancement and strengthening of bio-based

16 November 2017 to notify the Company in order to clarify the reasonableness of the assumptions used in the fair value measurement as well as publicly disclose the information. The Company engaged the

Management Discussion and Analysis For the Financial Result of Quarter 2 Year 2017 Ended June 30, 2017 Note: This Management Discussion and Analysis (MD&A) was made to disclose information and the

wishes to expand the scope of online branch office’s existing services, the intermediary shall notify the details of the expansion to the SEC Office at least 5 business days before the date of providing